Total Compensation FY2024
$20.2M
As reported in 2025 DEF 14A proxy filing with the SEC
Compensation Breakdown
Base Salary
$1.5M
7% of total
Stock Awards
$14.0M
69% of total
Bonus
$4.0M
20% of total
Other Compensation
$700,000
3% of total
Compensation History
Total compensation by fiscal year, as reported in SEC proxy filings.
About Karen Lynch
Karen Lynch has served as CVS Health's CEO since 2021, the highest-ranked woman on the Fortune 500.
Data Source: Compensation figures are sourced from CVS Health's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2024 as reported in the Summary Compensation Table.